Serum salicylic acid and fruit and vegetable consumption in obese and normal-weight children: a pilot-study

Carlotta Lassandro1,2, Giuseppe Banderali1, Benedetta Mariani1

  • 1a Department of Paediatrics , San Paolo Hospital , Department of Health Science (DISS) , University of Milan , Milan , Italy.

Insights

This study found that obese children have lower serum salicylic acid (SA) levels than normal-weight children. Fruit and vegetable intake did not correlate with SA levels in either group.

Area of Science:

  • Nutritional Science
  • Biochemistry
  • Pediatric Health

Background:

  • Salicylic acid (SA), a plant-derived phenolic compound, is recognized for potential health benefits.
  • Understanding factors influencing SA levels, such as diet, is crucial for public health.
  • Obesity is a growing concern in pediatric populations, with potential metabolic implications.

Purpose of the Study:

  • To investigate the association between serum salicylic acid (SA) levels and fruit and vegetable (FV) consumption in obese versus normal-weight children.
  • To compare SA levels and FV intake between obese and normal-weight pediatric groups.

Main Methods:

  • Pilot study involving 34 obese and 34 normal-weight children.
  • Dietary intake assessed using a 7-day dietary record.
  • Serum SA concentrations measured via gas chromatography-mass spectrometry.

Main Results:

  • No significant difference in daily fruit and vegetable intake was observed between obese and normal-weight children.
  • Obese children exhibited significantly lower serum SA levels compared to normal-weight children.
  • Serum SA levels showed no significant association with daily FV intake in either obese or normal-weight children.

Conclusions:

  • Obesity in children is linked to reduced serum salicylic acid levels.
  • Current fruit and vegetable intake metrics do not appear to correlate with serum SA in this pediatric cohort.
  • Further research is warranted to explore the specific types and quantities of fruits and vegetables influencing serum SA.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342